Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
Speaker 1 (00:00):
Gary Sadlmaier and Company kfab's morning news news broke yesterday,
of course, the former President Biden's prostate cancer diagnosis doesn't
sound good, of course, and we are joining for a
few minutes this morning by doctor Luke Nordquist, founder of
Eurology Cancer Center, now ex cancer, prominent eurologist here in
(00:20):
the Metro and a good friend, Doctor Luke.
Speaker 2 (00:22):
Good morning, Good morning Gary. Good to be honest with
you again.
Speaker 1 (00:25):
Great to have you back here. I all I know
about about this, I've learned from you. And one of
the things I've learned, and you were on here once
before and talked about the Gleason score being critical when
there's prostate cancer and we're told that Biden's Gleason score
is nine. That's not good, right.
Speaker 2 (00:44):
Well, I'm going to first correct. Yet I'd love to
be a eurologists and that's smart enough for that. Someone's
called a medical on college. I'm a cancer doctor, but
I specialized only in prostate cancer. So yeah, we see
about five hundred men a month of my cancer center
from coast to coast and even other countries. But yeah,
talking about pastay cancer, one of the most important things
you need to know is the Gleason score, not named
(01:06):
after the actor Jackie Bit. That's how you can remember it.
It's a number that you get from the biopsy. It's
the number from six to ten. There's no halves or
three quarters or five ahs. It's just six, seven, eight
nine or ten. And it tells us the aggressiveness of
the cancer. It's called the grade of the cancer. Every
cancer has a grade that tells us the aggressiveness, but
only prostate cancer is called the glease In grade, and
(01:29):
it really tells us how we're going to treat the cancer.
So like a glease in six are often the men
you hear about that they don't worry about prostate cancer.
It's a good cancer to have, you don't need to
treat it those people. Less than one percent of those
with their cancer ever spread, so often we can watch
it in any treatment is just extra side effects. But
when we get up to a glease in eight, nine
or ten, those are very aggressive. They can take lives.
(01:52):
There's still thirty seven thousand min a year that lose
their lives in the United States from prostate cancer. It's
the second leading cause of death from cancer behind lung cancer.
Out of all the hundreds of types of cancer, so
that's pretty serious, but those are mainly from glease in eight,
nines and tens.
Speaker 1 (02:07):
Yeah, what does the term stage four mean?
Speaker 2 (02:12):
Well, stage four most cancers mean that it's metastasized, it's spread,
and technically you could use that, but with prostate cancer
we don't tend to use the stage one through four
system as much. We call it either localized where it's contained,
let's try to cure it, or that it was recurs
with the rising PSA lab test, and then we have
(02:33):
metaphatic hormone sensitive and metaphatic hormone resistant. And the word
hormone means something here. So the male hormone testosterone is
the fuel for prostate cancer. For cancer, prostate cancer is
a car, that's the gasoline. And if we cure somebody
and their PSA goes to zero, then we don't care
what their PSA level is. But if somebody is going
(02:54):
to have this noncurable cancer in the body the rest
of their lives, then the whole of the prem treating
it is to lower or block the testosterone. What we
call hormone therapy, but it's kind of anti hormone therapy
because we're lowering or blocking testosterone. And even though it's
metastatic in his situation, and I've only read that it's
metastatic to the bones, I don't know if that's just
(03:15):
a couple spots what we would call oligo metastatic, because
if it's oligo metastatic, that means just one or two
spots in the bones, you might still go for cure. Well,
if it's truly metastatic, works in multiple spots, then it's
nonchurable but very treatable. And I have many many men
over ten years at least in eight nines and tens
with metastatic disease that are on different therapies, hormones, et
(03:38):
cetera to control the cancer for many years.
Speaker 1 (03:42):
I don't want to get you and drag you into
the political angle of this at all, but I'm just
curious what you'd think for a president of the United
States at the age of what was you down at
the last exam was eighty one? How likely is it
that he would not have been screened for stake cancer
at least gotten a PSA number.
Speaker 2 (04:04):
Well, I would say with an executive level, uh, for
somebody at that level would be having a yearly PSA
blood test. It's such a simple part of the channel.
I've been around a number of kind of VIP people,
or was in New York City. It's sloan kettering, and
you would often hear that they were diagnosed with prostate cancer,
(04:25):
and actually they'd been diagnosed and treated for the past
eight to ten years, and maybe it's towards the end
and they just wanted to come out to the public,
but they kept a private for the first number of
years for whatever reason. It would be very unlikely for
somebody diagnosed with a profday cancer, even at lease in
nine or ten, to have it already metastatic. So they
already haven't metastatic. It means it's probably been in that body,
probably somewhere at least three years, probably even closer to
(04:48):
five to six years, that it's already been in the
body with a PSA rising and likely detectable. So you know,
I'll just believe it at that I do. It's probably
been known for some time. They might instincts knowing what
I know, doing this for twenty one years.
Speaker 1 (05:02):
Yeah, and boy, you wonder, I wonder if there's been
treatment over those years. And I agree with you, it
seems very likely that they've known for a while. Well
they sure didn't share it with us, No, of course not.
Oh yeah, and that's that's a shame. But that has
nothing to do with it now because he's out of office.
Speaker 2 (05:20):
Right And to be honest, I don't know how much
it'd be with the cognition decline. Also, some people obviously say, well,
maybe it's spread to his brain. Different cancers spread the
different parts of the body. Standard prostaate cancer. If I see
five thousand visits a year, all of them except for
about fifty will be standard what we call admiral carcinoma,
the prosta which only spreads to bones and to linsnos.
(05:43):
It won't spread to the lung, liver, brain, places like that.
Now occasionally I use the example if a dog it's rabies,
it's still the same dog, but it's also got a
bad situation. Is what's called a neuroendocrine prostate cancer. That's
those extra fifty I'll see a year, which is like
rabies on prostate cancer. It can spread to the brain.
That is a very poor prognosis and people only typically
live a few months or maybe a year with that version.
(06:06):
But I don't think that's what he has.
Speaker 1 (06:08):
Well, the first thing I ever learned from you was
when we're just we just shoot the breeze about cancer,
is that whatever kind of cancer you have, wherever it spreads,
it's still that kind of cancer. So exactly, you know,
if it's on the bone, it's still prostate cancer.
Speaker 2 (06:23):
Yeah, exactly, It's like the danduli in seed blowing into
another part of the yard. It's still a dandulin right,
So that's true of all cancers. You're exactly right. And
when we have to work with when we're treating cancers,
because I see, well they're going to consider surgery radiational options. Well,
I doubt that we have surgery. We have radiation, we
have medicines. Those are three main tools to treat almost
every cancer. Surgery and radiation. For when it's all contained,
(06:45):
all the cowser in the barn, it's all in one spot.
Once it metastasizes, it's like weeds in your yard. You're
not going to go dig all of those up. And
I need use a medicine which goes everywhere, which could
be a pill, a shot, and immune therapy. These new therapnoptics,
I would be I'm surprised if you're not talking about
this new way of treating cancer called their anostics in
the future. Bill Gates has gotten into this type of therapy,
(07:07):
is starting a company and we're very involved in my center.
We've now done just our twenty third first in the
world with aeronoustics. These are starting to even give the
ability to cure advanced cancers in the future, so that's
very exciting.
Speaker 1 (07:18):
Excellent doctor nord Quest always got to chat. Thank you
for the time.
Speaker 2 (07:22):
Yeah, thanks Garry.
Gary Sadlmaier and Company kfab's morning news news broke yesterday,
of course, the former President Biden's prostate cancer diagnosis doesn't
sound good, of course, and we are joining for a
few minutes this morning by doctor Luke Nordquist, founder of
Eurology Cancer Center, now ex cancer, prominent eurologist here in
(00:20):
the Metro and a good friend, Doctor Luke.
Speaker 2 (00:22):
Good morning, Good morning Gary. Good to be honest with
you again.
Speaker 1 (00:25):
Great to have you back here. I all I know
about about this, I've learned from you. And one of
the things I've learned, and you were on here once
before and talked about the Gleason score being critical when
there's prostate cancer and we're told that Biden's Gleason score
is nine. That's not good, right.
Speaker 2 (00:44):
Well, I'm going to first correct. Yet I'd love to
be a eurologists and that's smart enough for that. Someone's
called a medical on college. I'm a cancer doctor, but
I specialized only in prostate cancer. So yeah, we see
about five hundred men a month of my cancer center
from coast to coast and even other countries. But yeah,
talking about pastay cancer, one of the most important things
you need to know is the Gleason score, not named
(01:06):
after the actor Jackie Bit. That's how you can remember it.
It's a number that you get from the biopsy. It's
the number from six to ten. There's no halves or
three quarters or five ahs. It's just six, seven, eight
nine or ten. And it tells us the aggressiveness of
the cancer. It's called the grade of the cancer. Every
cancer has a grade that tells us the aggressiveness, but
only prostate cancer is called the glease In grade, and
(01:29):
it really tells us how we're going to treat the cancer.
So like a glease in six are often the men
you hear about that they don't worry about prostate cancer.
It's a good cancer to have, you don't need to
treat it those people. Less than one percent of those
with their cancer ever spread, so often we can watch
it in any treatment is just extra side effects. But
when we get up to a glease in eight, nine
or ten, those are very aggressive. They can take lives.
(01:52):
There's still thirty seven thousand min a year that lose
their lives in the United States from prostate cancer. It's
the second leading cause of death from cancer behind lung cancer.
Out of all the hundreds of types of cancer, so
that's pretty serious, but those are mainly from glease in eight,
nines and tens.
Speaker 1 (02:07):
Yeah, what does the term stage four mean?
Speaker 2 (02:12):
Well, stage four most cancers mean that it's metastasized, it's spread,
and technically you could use that, but with prostate cancer
we don't tend to use the stage one through four
system as much. We call it either localized where it's contained,
let's try to cure it, or that it was recurs
with the rising PSA lab test, and then we have
(02:33):
metaphatic hormone sensitive and metaphatic hormone resistant. And the word
hormone means something here. So the male hormone testosterone is
the fuel for prostate cancer. For cancer, prostate cancer is
a car, that's the gasoline. And if we cure somebody
and their PSA goes to zero, then we don't care
what their PSA level is. But if somebody is going
(02:54):
to have this noncurable cancer in the body the rest
of their lives, then the whole of the prem treating
it is to lower or block the testosterone. What we
call hormone therapy, but it's kind of anti hormone therapy
because we're lowering or blocking testosterone. And even though it's
metastatic in his situation, and I've only read that it's
metastatic to the bones, I don't know if that's just
(03:15):
a couple spots what we would call oligo metastatic, because
if it's oligo metastatic, that means just one or two
spots in the bones, you might still go for cure. Well,
if it's truly metastatic, works in multiple spots, then it's
nonchurable but very treatable. And I have many many men
over ten years at least in eight nines and tens
with metastatic disease that are on different therapies, hormones, et
(03:38):
cetera to control the cancer for many years.
Speaker 1 (03:42):
I don't want to get you and drag you into
the political angle of this at all, but I'm just
curious what you'd think for a president of the United
States at the age of what was you down at
the last exam was eighty one? How likely is it
that he would not have been screened for stake cancer
at least gotten a PSA number.
Speaker 2 (04:04):
Well, I would say with an executive level, uh, for
somebody at that level would be having a yearly PSA
blood test. It's such a simple part of the channel.
I've been around a number of kind of VIP people,
or was in New York City. It's sloan kettering, and
you would often hear that they were diagnosed with prostate cancer,
(04:25):
and actually they'd been diagnosed and treated for the past
eight to ten years, and maybe it's towards the end
and they just wanted to come out to the public,
but they kept a private for the first number of
years for whatever reason. It would be very unlikely for
somebody diagnosed with a profday cancer, even at lease in
nine or ten, to have it already metastatic. So they
already haven't metastatic. It means it's probably been in that body,
probably somewhere at least three years, probably even closer to
(04:48):
five to six years, that it's already been in the
body with a PSA rising and likely detectable. So you know,
I'll just believe it at that I do. It's probably
been known for some time. They might instincts knowing what
I know, doing this for twenty one years.
Speaker 1 (05:02):
Yeah, and boy, you wonder, I wonder if there's been
treatment over those years. And I agree with you, it
seems very likely that they've known for a while. Well
they sure didn't share it with us, No, of course not.
Oh yeah, and that's that's a shame. But that has
nothing to do with it now because he's out of office.
Speaker 2 (05:20):
Right And to be honest, I don't know how much
it'd be with the cognition decline. Also, some people obviously say, well,
maybe it's spread to his brain. Different cancers spread the
different parts of the body. Standard prostaate cancer. If I see
five thousand visits a year, all of them except for
about fifty will be standard what we call admiral carcinoma,
the prosta which only spreads to bones and to linsnos.
(05:43):
It won't spread to the lung, liver, brain, places like that.
Now occasionally I use the example if a dog it's rabies,
it's still the same dog, but it's also got a
bad situation. Is what's called a neuroendocrine prostate cancer. That's
those extra fifty I'll see a year, which is like
rabies on prostate cancer. It can spread to the brain.
That is a very poor prognosis and people only typically
live a few months or maybe a year with that version.
(06:06):
But I don't think that's what he has.
Speaker 1 (06:08):
Well, the first thing I ever learned from you was
when we're just we just shoot the breeze about cancer,
is that whatever kind of cancer you have, wherever it spreads,
it's still that kind of cancer. So exactly, you know,
if it's on the bone, it's still prostate cancer.
Speaker 2 (06:23):
Yeah, exactly, It's like the danduli in seed blowing into
another part of the yard. It's still a dandulin right,
So that's true of all cancers. You're exactly right. And
when we have to work with when we're treating cancers,
because I see, well they're going to consider surgery radiational options. Well,
I doubt that we have surgery. We have radiation, we
have medicines. Those are three main tools to treat almost
every cancer. Surgery and radiation. For when it's all contained,
(06:45):
all the cowser in the barn, it's all in one spot.
Once it metastasizes, it's like weeds in your yard. You're
not going to go dig all of those up. And
I need use a medicine which goes everywhere, which could
be a pill, a shot, and immune therapy. These new therapnoptics,
I would be I'm surprised if you're not talking about
this new way of treating cancer called their anostics in
the future. Bill Gates has gotten into this type of therapy,
(07:07):
is starting a company and we're very involved in my center.
We've now done just our twenty third first in the
world with aeronoustics. These are starting to even give the
ability to cure advanced cancers in the future, so that's
very exciting.
Speaker 1 (07:18):
Excellent doctor nord Quest always got to chat. Thank you
for the time.
Speaker 2 (07:22):
Yeah, thanks Garry.
Popular Podcasts
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Amy Robach & T.J. Holmes present: Aubrey O’Day, Covering the Diddy Trial
Introducing… Aubrey O’Day Diddy’s former protege, television personality, platinum selling music artist, Danity Kane alum Aubrey O’Day joins veteran journalists Amy Robach and TJ Holmes to provide a unique perspective on the trial that has captivated the attention of the nation. Join them throughout the trial as they discuss, debate, and dissect every detail, every aspect of the proceedings. Aubrey will offer her opinions and expertise, as only she is qualified to do given her first-hand knowledge. From her days on Making the Band, as she emerged as the breakout star, the truth of the situation would be the opposite of the glitz and glamour. Listen throughout every minute of the trial, for this exclusive coverage. Amy Robach and TJ Holmes present Aubrey O’Day, Covering the Diddy Trial, an iHeartRadio podcast.
Good Hang with Amy Poehler
Come hang with Amy Poehler. Each week on her podcast, she'll welcome celebrities and fun people to her studio. They'll share stories about their careers, mutual friends, shared enthusiasms, and most importantly, what's been making them laugh. This podcast is not about trying to make you better or giving advice. Amy just wants to have a good time.